Adding value to liver (and allograft) biopsy evaluation using a combination of multiplex quantum dot immunostaining, high-resolution whole-slide digital imaging, and automated image analysis.

[1]  Yousef Al-Kofahi,et al.  Improved Automatic Detection and Segmentation of Cell Nuclei in Histopathology Images , 2010, IEEE Transactions on Biomedical Engineering.

[2]  Mark M. Davis,et al.  Cell type–specific gene expression differences in complex tissues , 2010, Nature Methods.

[3]  K. Isse,et al.  Histologic Graft Assessment After Clinical Islet Transplantation , 2009, Transplantation.

[4]  José Vassallo,et al.  Digital slides: present status of a tool for consultation, teaching, and quality control in pathology. , 2009, Pathology, research and practice.

[5]  Dylan Reilly,et al.  Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis. , 2009, Archives of pathology & laboratory medicine.

[6]  M. Montalto,et al.  From the incandescent light bulb to digital pathology: corporate innovation as an engine for change. , 2009, Archives of pathology & laboratory medicine.

[7]  Liron Pantanowitz,et al.  Impact of digital image manipulation in cytology. , 2009, Archives of pathology & laboratory medicine.

[8]  A. Gown,et al.  Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. , 2009, Archives of pathology & laboratory medicine.

[9]  J. Neuberger,et al.  Late protocol liver biopsies in the liver allograft: A neglected investigation? , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  Kristine A. Erps,et al.  Overview of telepathology, virtual microscopy, and whole slide imaging: prospects for the future. , 2009, Human pathology.

[11]  M. Henry,et al.  Automated cellular imaging system III for assessing HER2 status in breast cancer specimens: development of a standardized scoring method that correlates with FISH. , 2009, American journal of clinical pathology.

[12]  D. Rush.  Can protocol biopsy better inform our choices in renal transplantation? , 2009, Transplantation proceedings.

[13]  P. Nickerson,et al.  Urinary CXCL9 and CXCL10 Levels Correlate with the Extent of Subclinical Tubulitis , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  A. Israni,et al.  "Nature versus nurture" study of deceased-donor pairs in kidney transplantation. , 2009, Journal of the American Society of Nephrology : JASN.

[15]  I. Su,et al.  Enhanced expression of vascular endothelial growth factor‐A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis , 2009, Hepatology.

[16]  G. Jhangri,et al.  Molecular correlates of renal function in kidney transplant biopsies. , 2009, Journal of the American Society of Nephrology : JASN.

[17]  T. Therneau.  The perils and promise of high‐dimensional biology , 2009, Hepatology.

[18]  Y. N. Park,et al.  The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. , 2009, Journal of hepatology.

[19]  J. Zucman‐Rossi,et al.  Over‐expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[20]  T. Manabe,et al.  Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation , 2009, Transplantation.

[21]  Satoru Takahashi,et al.  High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humans. , 2009, Toxicology.

[22]  A. Demetris,et al.  Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[23]  A. Israni,et al.  HLA-A amino acid polymorphism and delayed kidney allograft function , 2008, Proceedings of the National Academy of Sciences.

[24]  V. Clay,et al.  Quantum dots light up pathology , 2008, The Journal of pathology.

[25]  J. Potter,et al.  Gene-set analysis and reduction , 2008, Briefings Bioinform..

[26]  C Womack,et al.  Quantitative multiplexed quantum dot immunohistochemistry. , 2008, Biochemical and biophysical research communications.

[27]  P. Parrilla,et al.  Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. , 2008, The Journal of clinical investigation.

[28]  A. Israni,et al.  Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  J. Neuberger,et al.  Protocol Liver Allograft Biopsies , 2008, Transplantation.

[30]  Yousef Al-Kofahi,et al.  Associative image analysis: A method for automated quantification of 3D multi-parameter images of brain tissue , 2008, Journal of Neuroscience Methods.

[31]  Y. Nakanuma,et al.  Pathology and immunopathology of immunoglobulin G4‐related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[32]  Cristel G. Thomas,et al.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.

[33]  P. Nickerson,et al.  Detection of Subclinical Tubular Injury After Renal Transplantation: Comparison of Urine Protein Analysis With Allograft Histopathology , 2007, Transplantation.

[34]  J. Bluestone,et al.  CD4+CD25+ Regulatory T Cells in Transplantation: Progress, Challenges and Prospects , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  R. Colvin.  Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. , 2007, Journal of the American Society of Nephrology : JASN.

[36]  S. Knechtle,et al.  Human CD4+CD25low Adaptive T Regulatory Cells Suppress Delayed-Type Hypersensitivity during Transplant Tolerance1 , 2007, The Journal of Immunology.

[37]  M. Ramoni,et al.  Multiparameter Immune Profiling of Operational Tolerance in Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[38]  Y. Li,et al.  Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. , 2007, Transplant immunology.

[39]  F. Reinholt,et al.  Liver biopsy interpretation for causes of late liver allograft dysfunction , 2006, Hepatology.

[40]  M. Fishbein,et al.  Phosphorylated S6 Ribosomal Protein: A Novel Biomarker of Antibody‐Mediated Rejection in Heart Allografts , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  S. Pittaluga,et al.  Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots , 2006, Modern Pathology.

[42]  M. Vuolo,et al.  HepPar1, MOC-31, pCEA, mCEA and CD10 for Distinguishing Hepatocellular Carcinoma vs. Metastatic Adenocarcinoma in Liver Fine Needle Aspirates , 2006, Acta Cytologica.

[43]  S. Hübscher,et al.  Progressive histological damage in liver allografts following pediatric liver transplantation , 2006, Hepatology.

[44]  V. Sharma,et al.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients. , 2005, The New England journal of medicine.

[45]  Alphonse E. Sirica,et al.  Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.

[46]  A. Demetris,et al.  Minimal Evidence of Transdifferentiation from Recipient Bone Marrow to Parenchymal Cells in Regenerating and Long‐Surviving Human Allografts , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  C. Morrison,et al.  A Comparison of CD10 to pCEA, MOC-31, and Hepatocyte for the Distinction of Malignant Tumors in the Liver , 2002, Modern Pathology.

[48]  A. Demetris,et al.  Real-time monitoring of acute liver-allograft rejection using the Banff schema1 , 2002 .

[49]  M. Dietel,et al.  Immunohistochemical double-staining of renal allograft tissue: critical assessment of three different protocols , 2002, Virchows Archiv.

[50]  B. McMahon,et al.  Chronic hepatitis B , 2001, Hepatology.

[51]  S. Finkelstein,et al.  Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications , 2001, Hepatology.

[52]  R. Wiesner,et al.  Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection , 2000, Hepatology.

[53]  B. Portmann,et al.  Tolerance and latent cellular rejection in long‐term liver transplant recipients , 1998, Hepatology.

[54]  Randall G. Lee,et al.  Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[55]  P. Bedossa,et al.  An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.

[56]  K. Batts,et al.  Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.

[57]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[58]  G. Bishop,et al.  A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: The use of monoclonal antibodies and double immunolabeling , 1990, Hepatology.

[59]  B. Iványi,et al.  Double and triple immunocytochemical labelling at the light microscope level in histopathology , 1990, The Histochemical Journal.

[60]  Y. Mizuguchi,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Estrogen Stimulates Female Biliary Epithelial Cell Interleukin-6 Expression in Mice and Humans , 2010 .

[61]  R. Coleman.  Can histology and pathology be taught without microscopes? The advantages and disadvantages of virtual histology. , 2009, Acta histochemica.

[62]  M Wang,et al.  Expression of Notch1, Jagged1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma. , 2009, Neoplasma.

[63]  A. Becker,et al.  Practical suggestions for successful immunoenzyme double-staining experiments , 2004, The Histochemical Journal.